Enacted July 23, 1974 (P.L. 93-352)
Committee Report No. 93-736 (March 20, 1974)-
The Committee on Labor and Public Welfare submitted the following report to accompany S. 2893. 93rd Congress, 2nd Session.
Excerpts from Committee Views
The committee is alarmed that the integrity and vitality of this Nation’s biomedical research program conducted largely by the NIH is now threatened. In enacting the National Cancer Act of 1971, the committee did not intend that increases for cancer research be funded at the expense of equally meritorious other biomedical research. Based upon testimony which the Committee received at its hearings on S.2893, the Committee believes decisive action is necessary to remedy this situation. Accordingly, on February 19, 1974, Senator Kennedy, introduced S.3023, a bill to establish a President’s Biomedical Research Panel to oversee and monitor the biomedical research program of the NIH (including the research programs of the NIMH).
The Medical Facilities Construction and Modernization Amendment of 1970 contained a provision designed to assure the availability and expenditure of appropriated health funds. This provision, unless amended, would expire on the first of July 1974. S. 2893 would permanently extend it.
The Committee, as well as the vast majority of witnesses who testified before it, believes that to effectively implement Section 408 (a), a provision must be made to permit the designation of more than the 15 new Comprehensive Cancer Centers stipulated in the National Cancer Act of 1971.
The Director of the National Cancer Program must be able to plan, manage, organize and assess the activities of the program with sufficient flexibility to maximize the program’s efforts. Therefore, the committee recommends changes to allow the Director, NCI, additional latitude in the management of the program.
The Committee is concerned about the loss of the independent authorities of the Director, NCI, to conduct a full range of communications, information and public affairs activities in support of the National Cancer Program. Therefore, the committee’s bill offers new provisions to provide independence for the Director in this regard.
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®